These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 1981851

  • 1. [Effect of N-(6-aminohexyl)-5-chloronaphthalene-1-sulfamide (W-7) and its analogs on the activity of soluble guanylate cyclase and on human platelet aggregation].
    Severina IS, Shirkov IuIu, Belushkina NN, Tyshchuk IA, Kulagin SV, Khropov IuV.
    Biokhimiia; 1990 Sep; 55(9):1717-24. PubMed ID: 1981851
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B, Grewe R, Loeschke K, Gerzer R.
    Pathol Biol (Paris); 1987 Feb 15; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [Abstract] [Full Text] [Related]

  • 8. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
    Chirkov IuIu, Belushkina NN, Tyshchuk IA, Severina IS.
    Biull Eksp Biol Med; 1991 Feb 15; 111(2):152-4. PubMed ID: 1677293
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ.
    Mol Pharmacol; 1983 May 15; 23(3):653-64. PubMed ID: 6135148
    [Abstract] [Full Text] [Related]

  • 10. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
    Severina IS, Bussygina OG, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1995 Jul 15; 36(4):913-25. PubMed ID: 8528155
    [Abstract] [Full Text] [Related]

  • 11. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG, Pyatakova NV, Khropov YV, Ovchinnikov IV, Makhova NN, Severina IS.
    Biochemistry (Mosc); 2000 Apr 15; 65(4):457-62. PubMed ID: 10810184
    [Abstract] [Full Text] [Related]

  • 12. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS.
    Biochemistry (Mosc); 1998 Jul 15; 63(7):794-801. PubMed ID: 9721331
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
    Brüne B, Ullrich V.
    Mol Pharmacol; 1987 Oct 15; 32(4):497-504. PubMed ID: 2890093
    [Abstract] [Full Text] [Related]

  • 14. [Inhibition of ADP-induced platelet aggregation by guanidine thiols--a novel class of guanylate cyclase activators and NO-synthase substrates].
    Belushkina NN, Severina IS.
    Biokhimiia; 1996 Dec 15; 61(12):2140-6. PubMed ID: 9156556
    [Abstract] [Full Text] [Related]

  • 15. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS.
    Vopr Med Khim; 2002 Dec 15; 48(1):4-30. PubMed ID: 12068497
    [Abstract] [Full Text] [Related]

  • 16. [A new class of soluble guanylate cyclase activators, generating nitric oxide].
    Riaposova IK, Grigor'ev NV, Severina IS.
    Biokhimiia; 1994 Apr 15; 59(4):537-42. PubMed ID: 7912551
    [Abstract] [Full Text] [Related]

  • 17. [The role of SH-groups in guanidine thiols--new substrates for NO-synthase--in stimulating the activity of guanylate cyclase].
    Busygina OG, Grigor'ev NB, Severina IS.
    Biokhimiia; 1996 Jan 15; 61(1):119-25. PubMed ID: 8679771
    [Abstract] [Full Text] [Related]

  • 18. The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
    Hering KW, Artz JD, Pearson WH, Marletta MA.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(3):618-21. PubMed ID: 16326101
    [Abstract] [Full Text] [Related]

  • 19. Derivatives of benzotetrazine-1,3-dioxide are new NO-donors, activators of soluble guanylate cyclase, and inhibitors of platelet aggregation.
    Pyatakova NV, Khropov YV, Churakov AM, Tarasova NI, Serezhenkov VA, Vanin AF, Tartakovsky VA, Severina IS.
    Biochemistry (Mosc); 2002 Mar 15; 67(3):329-34. PubMed ID: 11970731
    [Abstract] [Full Text] [Related]

  • 20. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
    Severina IS.
    Biull Eksp Biol Med; 1995 Mar 15; 119(3):230-5. PubMed ID: 7795182
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.